SLS SELLAS LIFE SCIENCES GROUP INC Investments/Divestments 8-K Filing 2024 - Collaboration Agreement GenFleet Therapeutics and Sellas Life Sciences Group have entered into a clinical trial collaboration and supply agreement with BeiGene Switzerland to initiate a combination study of GFH009 and BRUKINSA in treating diffuse large B-cell lymphoma (DLBCL).Get access to all SEC 8-K filings of the SELLAS LIFE SCIENCES GROUP INC